Assyro AI

FDA Orange Book · active-ingredient family

Timolol

Timolol is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:BETIMOL · NDA 020439

1

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution/drops

ProductApplicantApplicationTEApproved
BETIMOLRLD×2THEA PHARMANDA 020439Mar 31, 1995

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
TIMOLOLSOMERSETANDA 216654ATOct 10, 2024
TIMOLOL×2EPIC PHARMA LLCANDA 205309Sep 30, 2016

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Timolol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.